Physician profile
Derek A Einhorn
NPI 1801855762
$5,954.22
in general payments reported to CMS, 2019-2025
48 companies · $1,571 in 2025
The $1,571 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $324 · 2021: $365 · 2022: $1,005 · 2023: $984 · 2024: $1,401 · 2025: $1,571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,956.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $884.20 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $882.07 | 2021-2025 | |
| Novo Nordisk INC | $797.71 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $507.52 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $297.64 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $257.49 | 2019-2025 | Jardiance, Ofev |
| Exact Sciences Corporation | $216.85 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $204.04 | 2021-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $198.00 | 2019-2025 | Arexvy |
| Abbott Laboratories | $191.03 | 2022-2025 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $129.62 | 2022 | |
| Merck Sharp & Dohme LLC | $129.51 | 2019-2024 | Gardasil 9, Gardasil, Vaxneuvance |
| Amarin Pharma, INC. | $85.31 | 2019-2020 | |
| Cranial Technologies, INC | $82.44 | 2023-2024 | Doc Band |
| Dexcom, INC. | $81.05 | 2022-2024 | Dexcom G6 Transmitter |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Einhorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.